A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1997
11/06/1997	WO1997041232A1 Antagonists of interleukin-15
11/06/1997	WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	WO1997041230A2 Cc-type chemokines
11/06/1997	WO1997041229A1 Antibodies against interferon alpha/beta receptor
11/06/1997	WO1997041156A1 Novel compounds
11/06/1997	WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
11/06/1997	WO1997041104A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
11/06/1997	WO1997040848A1 Use of prolactin as a tgf-beta antagonist
11/06/1997	WO1997040839A1 Dna vaccine formulations
11/06/1997	WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	WO1997032598A3 Vaccines
11/06/1997	CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	CA2252675A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	CA2252557A1 Antagonists of interleukin-15
11/06/1997	CA2232682A1 Use of prolactin as a tgf-beta antagonist
11/05/1997	EP0805162A1 Peptide determinant associated with immunity
11/05/1997	EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997	EP0804597A1 Activation of t-cells by modified, antigenic immunoglobulins
11/05/1997	EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/05/1997	EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997	EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
11/05/1997	EP0804475A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease
11/05/1997	EP0804471A1 Gnrh antagonists
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804459A1 Therapeutic compound - fatty acid conjugates
11/05/1997	EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804411A1 Synthetic polyunsaturated fatty acid analogues
11/05/1997	EP0804238A1 Method to prevent transplant rejection
11/05/1997	EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4
11/05/1997	EP0804236A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
11/05/1997	EP0804218A1 Product and process for regulating signal transduction pathways
11/05/1997	EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
11/05/1997	EP0804212A2 $i(NIGELLA SATIVA) AS A MEDICINAL TREATMENT
11/05/1997	EP0804211A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria
11/05/1997	EP0804210A1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/05/1997	EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997	EP0804164A2 Method of priming an immune response in a one-day old animal
11/05/1997	EP0804076A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
11/05/1997	EP0636119B1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
11/05/1997	CN1164258A Nucleotide sequences of HIV-10 type (or subtype) O retrovirus antigens
11/05/1997	CN1164234A Pyrrolo £2,3-d\| pyrimidines and their use
11/05/1997	CN1164194A Remedy for diseases caused by IL-6 production
11/05/1997	CN1164191A Mutant enterotoxin effective as non-toxic oral adjuvant
11/05/1997	CN1164190A Cell growth regulator
11/05/1997	CN1163936A Recombination eukaryotic vector containing sensitinogen gene and application thereof
11/05/1997	CN1163895A Novel prodrugs for therapy of tumors and inflammatory disorders
11/04/1997	US5684204 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
11/04/1997	US5684145 Carrier system against GNRH
11/04/1997	US5684017 Antiarthritic agents, rheumatic diseases, antidiabetic agents for inhibiting interloeukins
11/04/1997	US5684010 Viricides
11/04/1997	US5683865 Method for diagnosis of mystery swine disease
11/04/1997	US5683701 Peptide fragments of HIV
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	CA2089607C Nutritional supplement for the elderly
11/04/1997	CA1339526C Recombinant myco-bacterial expression vehicles and uses therefor
10/1997
10/30/1997	WO1997040177A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	WO1997040161A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040149A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997	WO1997040134A2 Human dnase ii
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040068A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	WO1997040032A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
10/30/1997	WO1997040028A1 Urea derivatives as inhibitors of impdh enzyme
10/30/1997	WO1997040019A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
10/30/1997	WO1997040017A2 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997039749A2 Method for the prevention and treatment of cachexia and anorexia
10/30/1997	WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	WO1997035997A3 Recombinant pox virus encoding myelin protein for therapy
10/30/1997	DE19617864A1 Neue chirale Phenyldihydrofuranone New chiral Phenyldihydrofuranone
10/30/1997	CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2252439A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997	CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	CA2251584A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/29/1997	EP0803511A1 Allergenic proteins from ragweed and uses therefor
10/29/1997	EP0802924A1 Antibodies against t-cells as therapeutics
10/29/1997	EP0802921A1 Human pak65
10/29/1997	EP0802914A1 Aryl and heteroaryl purine compounds
10/29/1997	EP0802913A1 IMIDAZO 4,5-c]QUINOLINE AMINES
10/29/1997	EP0802912A1 Piperidine derivatives having tachykinin antagonist activity
10/29/1997	EP0802908A1 Novel compounds
10/29/1997	EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/29/1997	EP0802897A1 Novel compounds
10/29/1997	EP0802791A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
10/29/1997	EP0802731A1 Prophylactic treatment of allergic contact dermatitis
10/29/1997	EP0636136B1 2-aminosugar derivatives of macrolides
10/29/1997	CN1163610A Compounds and methods for treatment of cardiovascular, imflammatory and immune disorders
10/29/1997	CN1163270A Anti-hyerplasia and anti-inflammatory compound: pentose monosaccharide devivative
10/29/1997	CN1163268A Quinolinone derivatives and antianaphylactic agent containing said quinolinone devivative as biological active component

1 ... 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 ... 1172